I found that a lot of sites talk about this news: a research team from Hong Kong university invented a universal antibody drug for HIV-1 and they tested that in mice news source.

Basically, they propose an engineered tandem bispecific broadly neutralizing antibody (bs-bnAb) as an innovative product for HIV-1 prophylactic and therapeutic interventions.

How promising is this recent research?

  • 2
    The study does exist and is available here. I'm interested to hear what others think about the significance of this study. But the researchers themselves point out: It should be noted that HIV-1–infected humanized NSG-HuPBL mice do not fully represent infected patients, although this model has been widely used to study bnAb-based HIV-1 immunotherapy To me, this seems more like a new direction of research than anywhere near to a drug.
    – Narusan
    Jun 4, 2018 at 13:02


Your Answer

By clicking “Post Your Answer”, you agree to our terms of service and acknowledge you have read our privacy policy.

Browse other questions tagged or ask your own question.